Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLEMASTINE vs CLEVIDIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLEMASTINE vs CLEVIDIPINE: Safety Overview

Metric CLEMASTINE CLEVIDIPINE
Total FAERS Reports 611 201
Deaths Reported 54 5
Death Rate 8.8% 2.5%
Hospitalizations 319 20
Average Patient Age 50.8 yrs 61.9 yrs
% Female Patients 72.1% 32.7%
FDA Approval Date Approved Prior to Jan 1, 1982 Aug 1, 2008
Manufacturer Genus Lifesciences Fresenius Kabi Austria GmbH
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription